HER2 polymorphism is associated with gastric cancer risk

被引：0
|
作者：
Pinto, D. [1 ]
Faustino, C. [2 ]
Ferreira, P. [2 ]
Teixeira, A. L. [1 ]
Pinto-Correia, A. L. [1 ]
Sousa, H. [1 ]
Dinis-Ribeiro, M. [3 ]
Fragoso, M. [2 ]
Medeiros, R. [1 ]
机构：
[1] Inst Portugues Oncol Porto FG EPE, Mol Oncol Grp, CI Lab 40 Piso, Oporto, Portugal
[2] Inst Portugues Oncol Porto FG EPE, Dept Med Oncol, Oporto, Portugal
[3] Inst Portugues Oncol Porto FG EPE, Gastroenterol Serv, Oporto, Portugal
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70344-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
326
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [41] Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan
    Nai-Wen Chang
    Dar-Ren Chen
    Chen-Ten Wu
    Bradley E. Aouizerat
    Fei-Na Chen
    Shin-Jer Hung
    Shiuan-Huei Wang
    Ming-Feng Wei
    Cheng-Shyong Chang
    Breast Cancer Research and Treatment, 2005, 90 : 257 - 261
  • [42] Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan
    Chang, NW
    Chen, DR
    Wu, CT
    Aouizerat, BE
    Chen, FN
    Hung, SJ
    Wang, SH
    Wei, MF
    Chang, CS
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (03) : 257 - 261
  • [43] HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
    Akio Kaito
    Takeshi Kuwata
    Masanori Tokunaga
    Kohei Shitara
    Reo Sato
    Tetsuo Akimoto
    Takahiro Kinoshita
    World Journal of Clinical Cases, 2019, (15) : 1964 - 1977
  • [44] HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
    Kaito, Akio
    Kuwata, Takeshi
    Tokunaga, Masanori
    Shitara, Kohei
    Sato, Reo
    Akimoto, Tetsuo
    Kinoshita, Takahiro
    WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (15) : 1964 - 1977
  • [45] HER2 positivity in advanced gastric cancer is comparable to breast cancer
    Leon-Chong, J.
    Lordick, F.
    Kang, Y. K.
    Park, S. R.
    Bang, Y. J.
    Sawaki, A.
    Van Cutsem, E.
    Stoss, O.
    Jordan, B. W.
    Feyereislova, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] SERUM HER2 EXTRACELLULAR DOMAIN LEVELS AND TISSUE HER2 OVEREXPRESSION IN ADVANCED GASTRIC CANCER PATIENTS
    Takahashi, Y.
    Ohori, H.
    Takahashi, M.
    Gamoh, M.
    ANNALS OF ONCOLOGY, 2013, 24 : 32 - 32
  • [47] Epidemiologic study on HER2 (+) early/advanced stage gastric cancer: An evaluation on HER2 positivity in gastric and gastroesophageal junction cancers
    Erdamar, S.
    Kepil, N.
    Dursun, A.
    Ekinci, O.
    Sagol, O.
    Sarioglu, S.
    Doganavsargil, B.
    Sezak, M.
    Ozdener, F.
    Ustundag, K.
    VIRCHOWS ARCHIV, 2014, 465 : S148 - S148
  • [48] Treatment of HER2 Positive Advanced Gastric Cancer: Deviations in HER2 Results and Its Impact on Survival
    Haffner, Ivonne
    Schierle, Katrin
    Maier, Dieter
    Geier, Birgitta
    Raimundez, Elba
    Hasenauer, Jan
    Luber, Birgit
    Kretzschmar, Albrecht
    von Weikersthal, Ludwig Fischer
    Ahlborn, Miriam
    Riera, Jorge
    Rau, Beate
    Siegler, Gabriele
    Fuxius, Stefan
    Decker, Thomas
    Wittekind, Christian
    Lordick, Florian
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 65 - 65
  • [49] Retrospective HER2 testing in gastric cancer biopsy specimens
    Bjelkenkrantz, K.
    Edsjo, A.
    VIRCHOWS ARCHIV, 2011, 459 : S160 - S161
  • [50] DETERMINATION OF THE HER2 EXPRESSION IN CHILEAN PATIENTS WITH GASTRIC CANCER
    Painemal, Claudio
    Berrios, Marcela
    Gallegos, Ivan
    San Martin, Carmen
    Villanueva, Luis
    Barajas, Olga
    Ahumada, Monica
    Fuentes, Rodrigo
    ANNALS OF ONCOLOGY, 2012, 23 : 50 - 50
12345